AAFPRS President Addresses Concerns About Moderna COVID-19 Vaccine
AAFPRS will continue monitoring reports of incidents of reactions in patients with dermal fillers who received the Moderna COVID-19 vaccine.
AAFPRS will continue monitoring reports of incidents of reactions in patients with dermal fillers who received the Moderna COVID-19 vaccine.
The FDA has cleared the SkinStylus microneedling device for the improvement of periorbital wrinkles in adults aged 22 years and older across all Fitzpatrick skin types, expanding the device's FDA-cleared indications to include facial acne scars, periorbital wrinkles, and abdominal scars.